Association of Abnormal Preoperative Laboratory Values with Survival After Radical Nephrectomy for Clinically Confined Clear Cell Renal Cell Carcinoma

Urology

Volumn 71, Issue 2, 2008, Pages 278-282

  Magera Jr , James S ^a   Leibovich, Bradley C ^a   Lohse, Christine M ^a   Sengupta, Shomik ^a   Cheville, John C ^a   Kwon, Eugene D ^a   Blute, Michael L ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE;

ANEMIA; ARTICLE; CALCIUM BLOOD LEVEL; CANCER STAGING; CLINICAL FEATURE; CONTROLLED STUDY; ERYTHROCYTE SEDIMENTATION RATE; FOLLOW UP; HUMAN; HYPERCALCEMIA; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; NEPHRECTOMY; PREOPERATIVE CARE; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL; TREATMENT OUTCOME;

CARCINOMA, RENAL CELL; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY NEOPLASMS; MALE; NEPHRECTOMY; PREOPERATIVE CARE; PROGNOSIS; SURVIVAL RATE;

EID: 39549105788     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2007.08.048     Document Type: Article

References (24)

1. Jemal A., Murray T., Ward E., et al. Cancer statistics, 2005. CA Cancer J Clin 55 (2005) 10-30
2. Leibovich B.C., Blute M.L., Cheville J.C., et al. Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: a stratification tool for prospective clinical trials. Cancer 97 (2003) 1663-1671
3. Srigley J.R., Hutter R.V., Gelb A.B., et al. Current prognostic factors: renal cell carcinoma: Workgroup No. 4. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC). Cancer 80 (1997) 994-996
4. Gelb A.B. Renal cell carcinoma: current prognostic factors. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC). Cancer 80 (1997) 981-986
5. Motzer R.J., Mazumdar M., Bacik J., et al. Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma. J Clin Oncol 17 (1999) 2530-2540
6. Zisman A., Pantuck A.J., Dorey F., et al. Improved prognostication of renal cell carcinoma using an integrated staging system [see comment]. J Clin Oncol 19 (2001) 1649-1657
7. Frank I., Blute M.L., Cheville J.C., et al. An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: the SSIGN score. J Urol 168 (2002) 2395-2400
8. Kim H.L., Belldegrun A.S., Freitas D.G., et al. Paraneoplastic signs and symptoms of renal cell carcinoma: implications for prognosis. J Urol 170 (2003) 1742-1746
9. Cheville J.C., Lohse C.M., Zincke H., et al. Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma. Am J Surg Pathol 27 (2003) 612-624
10. Furge K.A., Lucas K.A., Takahashi M., et al. Robust classification of renal cell carcinoma based on gene expression data and predicted cytogenetic profiles. Cancer Res 64 (2004) 4117-4121
11. Junker K., Weirich G., Amin M.B., et al. Genetic subtyping of renal cell carcinoma by comparative genomic hybridization. Recent Res Cancer Res 162 (2003) 169-175
12. Sengupta S., Lohse C.M., Leibovich B.C., et al. Histologic coagulative tumor necrosis as a prognostic indicator of renal cell carcinoma aggressiveness. Cancer 104 (2005) 511-520
13. Storkel S., Eble J.N., Adlakha K., et al. Classification of renal cell carcinoma: Workgroup No. 1. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC). Cancer 80 (1997) 987-989
14. Kovacs G., Akhtar M., Beckwith B.J., et al. The Heidelberg classification of renal cell tumours. J Pathol 183 (1997) 131-133
15. Frank I., Blute M.L., Cheville J.C., et al. A multifactorial postoperative surveillance model for patients with surgically treated clear cell renal cell carcinoma [see comment]. J Urol 170 (2003) 2225-2232
16. Gold P.J., Fefer A., and Thompson J.A. Paraneoplastic manifestations of renal cell carcinoma. Semin Urol Oncol 14 (1996) 216-222
17. Fahn H.J., Lee Y.H., Chen M.T., et al. The incidence and prognostic significance of humoral hypercalcemia in renal cell carcinoma. J Urol 145 (1991) 248-2450
18. Spivak J.L. The anaemia of cancer: death by a thousand cuts. Nat Rev Cancer 5 (2005) 543-555
19. Pantuck A.J., Zeng G., Belldegrun A.S., et al. Pathobiology, prognosis, and targeted therapy for renal cell carcinoma: exploiting the hypoxia-induced pathway. Clin Cancer Res 9 (2003) 4641-4652
20. Nacey J.N., and Delahunt B. Renal cell carcinoma: I. Clinical indicators of prognosis. N Z Med J 99 (1986) 531-533
21. Sene A.P., Hunt L., McMahon R.F., et al. Renal carcinoma in patients undergoing nephrectomy: analysis of survival and prognostic factors. Br J Urol 70 (1992) 125-134
22. Sengupta S., Lohse C.M., Cheville J.C., et al. The preoperative erythrocyte sedimentation rate is an independent prognostic factor in renal cell carcinoma. Cancer 106 (2006) 304-312
23. Stauffer M.H. Nephrogenic hepatosplenomegaly. Gastroenterology 40 (1961) 694-695
24. Chuang Y.C., Lin A.T., Chen K.K., et al. Paraneoplastic elevation of serum alkaline phosphatase in renal cell carcinoma: incidence and implication on prognosis. J Urol 158 (1997) 1684-1687